We have read with great interest the study of Stolee et al.
were receiving chronic treatment with psychoactive drugs: 308 (35.3%) benzodiazepines, 103 (11.8%) nonbenzodiazepine hypnotics, 107 (12.2%) neuroleptics, and 232 (26.6%) antidepressants (22 tricyclic antidepressants and 211 serotonin uptake inhibitors and/or noradrenaline).
The mean number of falls during the year prior to assessment was 2.3 ± 1.8. A total of 302 (34.6%) patients had not suffered any previous fall and 190 (22%) patients had fallen more than twice during the previous year. The cause of the fall was identifi ed as intrinsic in 365 (41.8%) cases, extrinsic in 357 (40.9%), and combined in 150 (17.3%). Our results show that the profi les of fall-related hip fracture patients are very similar wherever the fall occurs. Indeed, there are only a few important differences between institutional and community residents. Among community-dwelling patients, there was a predominance of females, married participants, those with better functionality in terms of daily living activities, as quantifi ed by the Barthel index, and less comorbidity (Charlson comorbidity index). In contrast, institutionalized patients had more dementia, greater overall and psychoactive drug consumption, and a higher percentage of visual defi cits.
These results, in our area, show the importance of the chronic consumption of some drugs in relation to the falls associated with a hip fracture and confi rm ( 1 ) that cognitive impairment and previous falls are risk factors for hip fracture in non -community-dwelling participants . Chronic consumption of psychoactive drugs (benzodiazepines and antidepressants) has been associated with a greater number of falls, although some studies have found no direct association ( 4 -6 ). As, in our investigation, all patients had suffered a fall, the study was not designed to analyze the risk of falls leading to hip fracture according to whether participants were taking psychoactive drugs. However, the results show that a high percentage of patients were being treated with benzodiazepines and antidepressants, especially institutionalized patients. The use of benzodiazepines in the institutionalized elderly patients with dementia is probably avoidable in most cases. 
